Pathophysiology of renal tubular obstruction: therapeutic role of synthetic RGD peptides in acute renal failure.
Noiri
E
E
Department of Medicine, State University of New York at Stony Brook, USA.
Romanov
V
V
Forest
T
T
Gailit
J
J
DiBona
G F
GF
Miller
F
F
Som
P
P
Oster
Z H
ZH
Goligorsky
M S
MS
D058186:Acute Kidney Injury / Q000150:complications / Q000188:drug therapy*; D000595:Amino Acid Sequence; D000818:Animals; D003251:Constriction, Pathologic; D006801:Humans; D016023:Integrins / Q000502:physiology; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D007684:Kidney Tubules / Q000503:physiopathology*; D009842:Oligopeptides / Q000138:chemical synthesis / Q000627:therapeutic use*; D010446:Peptide Fragments / Q000627:therapeutic use
D016023:Integrins; D009842:Oligopeptides; D010446:Peptide Fragments; C047981:arginyl-glycyl-aspartic acid